Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

20 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Anti-macular degeneration agents.
Rothen M, Jablon E, Monares G, Fontal MR, Alfaro DV 3rd. Rothen M, et al. Among authors: jablon e. Ophthalmol Clin North Am. 2005 Dec;18(4):561-7. doi: 10.1016/j.ohc.2005.07.009. Ophthalmol Clin North Am. 2005. PMID: 16314219 Review.
Fishing-related ocular trauma.
Alfaro DV 3rd, Jablon EP, Rodriguez Fontal M, Villalba SJ, Morris RE, Grossman M, Roig-Melo E. Alfaro DV 3rd, et al. Among authors: jablon ep. Am J Ophthalmol. 2005 Mar;139(3):488-92. doi: 10.1016/j.ajo.2004.10.011. Am J Ophthalmol. 2005. PMID: 15767058
Metabolic control and diabetic retinopathy.
Rodriguez-Fontal M, Kerrison JB, Alfaro DV, Jablon EP. Rodriguez-Fontal M, et al. Curr Diabetes Rev. 2009 Feb;5(1):3-7. doi: 10.2174/157339909787314176. Curr Diabetes Rev. 2009. PMID: 19199891 Review.
Diabetic retinopathy and angiogenesis.
Crawford TN, Alfaro DV 3rd, Kerrison JB, Jablon EP. Crawford TN, et al. Curr Diabetes Rev. 2009 Feb;5(1):8-13. doi: 10.2174/157339909787314149. Curr Diabetes Rev. 2009. PMID: 19199892 Review.
Ranibizumab for diabetic retinopathy.
Rodriguez-Fontal M, Alfaro V, Kerrison JB, Jablon EP. Rodriguez-Fontal M, et al. Curr Diabetes Rev. 2009 Feb;5(1):47-51. doi: 10.2174/157339909787314239. Curr Diabetes Rev. 2009. PMID: 19199898 Review.
A randomized trial comparing the efficacy and safety of intravitreal triamcinolone with observation to treat vision loss associated with macular edema secondary to central retinal vein occlusion: the Standard Care vs Corticosteroid for Retinal Vein Occlusion (SCORE) study report 5.
Ip MS, Scott IU, VanVeldhuisen PC, Oden NL, Blodi BA, Fisher M, Singerman LJ, Tolentino M, Chan CK, Gonzalez VH; SCORE Study Research Group. Ip MS, et al. Arch Ophthalmol. 2009 Sep;127(9):1101-14. doi: 10.1001/archophthalmol.2009.234. Arch Ophthalmol. 2009. PMID: 19752419 Free PMC article. Clinical Trial.
A randomized trial comparing the efficacy and safety of intravitreal triamcinolone with standard care to treat vision loss associated with macular Edema secondary to branch retinal vein occlusion: the Standard Care vs Corticosteroid for Retinal Vein Occlusion (SCORE) study report 6.
Scott IU, Ip MS, VanVeldhuisen PC, Oden NL, Blodi BA, Fisher M, Chan CK, Gonzalez VH, Singerman LJ, Tolentino M; SCORE Study Research Group. Scott IU, et al. Arch Ophthalmol. 2009 Sep;127(9):1115-28. doi: 10.1001/archophthalmol.2009.233. Arch Ophthalmol. 2009. PMID: 19752420 Free PMC article. Clinical Trial.
Incidence, Risk Factors, and Timing of Elevated Intraocular Pressure After Intravitreal Triamcinolone Acetonide Injection for Macular Edema Secondary to Retinal Vein Occlusion: SCORE Study Report 15.
Aref AA, Scott IU, Oden NL, Ip MS, Blodi BA, VanVeldhuisen PC; SCORE Study Investigator Group. Aref AA, et al. JAMA Ophthalmol. 2015 Sep;133(9):1022-9. doi: 10.1001/jamaophthalmol.2015.1823. JAMA Ophthalmol. 2015. PMID: 26086920 Free PMC article. Clinical Trial.
20 results